BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37777411)

  • 21. Therapeutic potential of targeting
    Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
    Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
    Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
    Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel alternative splicing-related prognostic signature for osteosarcoma.
    Zhang J; Liang J; Chang X; Ge R
    Asian J Surg; 2023 Dec; 46(12):5882-5884. PubMed ID: 37659943
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    He S; Xiao Z; Chen L; Xiong S
    Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
    [No Abstract]   [Full Text] [Related]  

  • 25. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".
    Li Z; Li Y
    Tumour Biol; 2014 May; 35(5):5051. PubMed ID: 24390666
    [No Abstract]   [Full Text] [Related]  

  • 27. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profiles of osteosarcoma that can predict response to chemotherapy.
    Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
    Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel prognostic signature in osteosarcoma characterised from the perspective of unfolded protein response.
    Shi C; Zhao F; Zhang T; Xu D; Hao Z; Cui F; Shi JH; Jin Y; Li N; Yang C; Zhang Y; Sheng X
    Clin Transl Med; 2022 Mar; 12(3):e750. PubMed ID: 35343090
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular classification of osteosarcoma.
    Lau CC
    Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of mitochondrial-related signature and molecular subtype for the prognosis of osteosarcoma.
    Zhao X; Zhang J; Liu J; Chen Q; Cai C; Miao X; Wu T; Cheng X
    Aging (Albany NY); 2023 Nov; 15(22):12794-12816. PubMed ID: 37976137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
    Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
    Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial osteogenic sarcoma.
    Swaney JJ
    Clin Orthop Relat Res; 1973; (97):64-8. PubMed ID: 4521231
    [No Abstract]   [Full Text] [Related]  

  • 36. Retinoblastoma and osteosarcoma: the prototypic cancer family.
    Hansen MF; Cavenee WK
    Acta Paediatr Jpn; 1987 Aug; 29(4):526-33. PubMed ID: 3144887
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
    Hong Q; Fang J; Pang Y; Zheng J
    Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of CCN3 in osteosarcoma.
    Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
    Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characterization of Cell Subsets Associated With Prognosis of Osteosarcoma Based on Single-Cell Sequencing Data].
    Wang ST; Zhu HR; Xu SJ; Gui P; Chen MZ; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):773-782. PubMed ID: 37927019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.